Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?

Am J Med Sci

Strategic Center for Diabetes Research, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address:

Published: October 2020

Severe Acute Respiratory Distress Syndrome caused by a novel human coronavirus SARS-CoV-2 named COVID-19 and declared as a pandemic. This paper reviews the possibility of repurposing angiotensin type 1 receptor (AT1R) antagonists and vitamin D to treat COVID-19. ACE2 protein found on the cell membranes is the target of SARS-CoV-2 for entering into the host cells. Viral spike protein-binding with ACE2 down-regulates it. As ACE2 is known to protect the lung from injuries, SARS-CoV-2-induced ACE2 deficiency may expose patients to lung damage. AT1R antagonists and vitamin D increase the expression of ACE2 independently. Besides, vitamin D suppresses the compensatory increase in renin levels following the inhibition of the renin-angiotensin system by AT1R antagonists. Therefore, a combination of AT1R antagonists and vitamin D may offer protection against COVID-19 induced lung injury.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362851PMC
http://dx.doi.org/10.1016/j.amjms.2020.07.018DOI Listing

Publication Analysis

Top Keywords

at1r antagonists
16
antagonists vitamin
12
combination at1r
8
vitamin treat
8
vitamin
5
ace2
5
at1r antagonist
4
antagonist vitamin
4
lung
4
treat lung
4

Similar Publications

Direct Vascular Effects of Angiotensin II (A Systematic Short Review).

Int J Mol Sci

December 2024

Department of Physiology, Faculty of Medicine, Semmelweis University, 37-47 Tűzoltó Street, 1094 Budapest, Hungary.

The octapeptide angiotensin II (Ang II) is a circulating hormone as well as a locally formed agonist synthesized by the angiotensin-converting enzyme (ACE) of endothelial cells. It forms a powerful mechanism to control the amount and pressure of body fluids. All main effects are directed to save body salt and water and ensure blood pressure under basic conditions and in emergencies.

View Article and Find Full Text PDF

Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats.

Brain Res Bull

January 2025

Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Shaanxi Engineering and Research Center of Vaccine, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry of China, Xi'an 710061, China. Electronic address:

Neuromedin B (NMB) has potentially great impacts on the development of cardiovascular diseases by promoting hypertensive and sympatho-excitation effects. However, studies regarding the NMB function in paraventricular nucleus (PVN) are lacking. With selective neuromedin B receptor (NMBR) antagonist, BIM-23127, we aim to determine whether the blockade of NMB function in PVN could alleviate central inflammation and attenuate hypertensive responses.

View Article and Find Full Text PDF

The prevalence of hypertension increases with age and is the leading modifiable risk factor for cognitive impairment and dementia. At present, the neural mechanisms promoting hypertension across the lifespan are incompletely understood. Using the Sprague-Dawley (SD) rat as a model of normal aging, we hypothesized (1) blood brain barrier (BBB) disruption and neuroinflammation in the paraventricular nucleus (PVN) of the hypothalamus enhances sympathetic tone and contributes to age-dependent hypertension, (2) age-dependent hypertension is associated with cognitive impairment, and (3) lowering blood pressure in aged rats with established hypertension improves cognitive function.

View Article and Find Full Text PDF
Article Synopsis
  • * A study of 402 Brazilian CD patients analyzed genetic polymorphisms in genes related to CD and its progression to determine associations with CARD severity, using logistic regression to adjust for factors like age and treatment.
  • * Although some genetic variants suggested potential links to CARD severity, no strong associations were confirmed after adjusting for multiple comparisons, while a specific haplotype showed protective effects against severe CARD progression.
View Article and Find Full Text PDF

Background: Advancing age could influence renin angiotensin system components, especially angiotensin type 1 receptor (AT1R). This study examined the effect of AT1R antagonist, losartan, on age-related differences in renal vascular responses to angiotensin II in male and female rats.

Materials And Methods: Forty-eight anesthetized male and female rats (8-12 and 24-28 weeks age ranges) were subjected to catheterize.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!